CD4 and metabolic syndrome: The rs1130214 has been associated with persistently high CD4+ T cell glycolytic activity in HIV-positive individuals (10), increased risk of having congenital heart disease (12), glucose homeostasis and metabolic syndrome (9), among other conditions.